Meformin Fairmed

Metformin Hydrochloride, the active ingredient in Meformin Fairmed, is a biguanide presented as an oral tablet for oral use. Originating from the European Union market, it lowers elevated blood glucose in adults with type 2 diabetes mellitus and is prescribed as part of standard glycemic control regimens.

GNH USA supplies Meformin Fairmed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable sourcing, regulatory documentation and logistics support for global healthcare providers, and ensuring product integrity throughout the supply chain.

Meformin Fairmed (metformin) is used in the management of disorders related to impaired glucose regulation.

Type 2 diabetes mellitus: improves glycemic control and reduces HbA1c levels. Prediabetes: may help normalize fasting glucose and delay onset of diabetes. Polycystic ovary syndrome: can improve insulin sensitivity and assist in menstrual regulation.

Metformin Hydrochloride may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Gastrointestinal upset: nausea, abdominal discomfort, or loss of appetite. - Diarrhea: loose stools that may be watery. - Metallic taste: transient metallic sensation in the mouth. - Vitamin B12 deficiency: reduced absorption with long‑term use.

Serious or Rare Side Effects: - Lactic acidosis: rare but potentially fatal accumulation of lactate. - Severe hypoglycemia: usually when combined with other glucose‑lowering agents. - Hepatic failure: marked liver enzyme elevation or liver dysfunction.

When prescribing Metformin Hydrochloride, clinicians should observe several precautionary measures to ensure patient safety.

Renal function assessment: evaluate creatinine clearance before initiation and periodically. Hepatic function monitoring: avoid use in patients with significant liver disease. Contraindication review: do not use in patients with known hypersensitivity to metformin. Elderly patient caution: start at lower dose and monitor for accumulation. Concomitant medication review: assess for drugs that may affect renal clearance. Store at room temperature: keep in the original container, protect from moisture and heat.

Metformin Hydrochloride can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate acute renal failure and increase risk of lactic acidosis. - Cimetidine: can reduce renal clearance of metformin, raising plasma levels. - Alcohol excess: potentiates risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycemia symptoms. - ACE inhibitors or ARBs: can affect renal function, requiring dose adjustment. - Warfarin: may increase INR, necessitating closer coagulation monitoring.